Market News & Trends
Profiling Metal Content in Parenteral Grade Protein Stabilizers
By: Jason Forbes, Larry Lonski, and Christopher Wilcox Sucrose, Trehalose, Mannitol, and Maltose are four of the most commonly utilized carbohydrates for protein stabilization in…
Halozyme to Resume Pancreatic Cancer Trial
Halozyme Therapeutics, Inc. recently announced that the US FDA has removed the clinical hold on patient enrollment and dosing of PEGPH20 in the ongoing Phase…
Transition Therapeutics to Receive up to $30.8 Million
Transition Therapeutics Inc. recently announced that Jack W. Schuler , Larry N. Feinberg, Oracle Investment Management, certain Transition Board members, management, and other existing shareholders…
Lubrizol Introduces New Pharmaceutical Excipient
The Lubrizol LifeScience Polymers (LSP) business announces the introduction of a new pharmaceutical-grade excipient, Pathway. As pharmaceutical companies face the challenge of the patent cliff,…
A Rise in IPOs Revive Investments for Global Pharma & Biotech Industry
The heightened private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008-2010, witnessed a decline post-2010. However,…
Novozymes Biopharma Enters Agreement With Leading Vaccine Company
Novozymes Biopharma has entered a new collaborative research agreement with one of the world’s top vaccine companies. The partnership will enable the company to evaluate…
Capsugel & Bend Research Announce New Commercial-Scale Spray-Dried Dispersion Capacity
Bend Research, a division of Capsugel Dosage Form Solutions (DFS), recently announced it has installed its first commercial-scale spray-dryer in its R&D facility in Bend,…
Ipca & Oncobiologics Create Strategic Biosimilars Partnership
Ipca Laboratories Ltd. and Oncobiologics, Inc. recently announced the creation of a two-part alliance for the development, manufacture, and commercialization of biosimilar monoclonal antibody products.…
Personalized Medicine Drives Uptake of Next-Generation Sequencing in Europe, Finds Frost & Sullivan
The Western European next-generation sequencing (NGS) market is poised for steady growth, owing to the emergence of new applications, such as non-invasive prenatal testing and…
Vietnam’s Pharmaceutical Market Value to Hit $8 Billion by 2020
The pharmaceutical market in Vietnam is set to increase in value by $5 billion over the next 6 years, reaching a net worth of $8…
A Rise in IPOs Revive Investments for Global Pharma & Biotech Industry
The heightened private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008-2010, witnessed a decline post-2010.…
Third Rock Ventures & The Column Group Launch Nurix
Third Rock Ventures and The Column Group recently announced the launch of Nurix, Inc., a leader in discovering and developing therapies that modulate the ubiquitin…
PolyTherics & Antitope Form Abzena
PolyTherics Limited recently announced the formation of a new company, Abzena Limited. The new company has been created to provide a strong group identity across…
BioAlliance Pharma, TopoTarget A/S to Merge
BioAlliance Pharma SA and Topotarget A/S recently announced the signature of a definitive merger plan to create the combination of BioAlliance Pharma SA and Topotarget…
Viking Signs Broad Licensing Deal With Ligand
Viking Therapeutics, Inc. recently announced it has obtained an exclusive worldwide license to five novel therapeutic programs from Ligand Pharmaceuticals Incorporated. The license includes programs…
GlycoMimetics Receives $15-Million Payment From Pfizer
GlycoMimetics, Inc. recently announced that Pfizer has made a $15-million payment to GlycoMimetics under the terms of the parties’ collaboration for the development of rivipansel…
Adamas Pharmaceuticals Receives $25-Million Milestone Payment From Forest Laboratories
Adamas Pharmaceuticals, Inc. recently announced it has received a $25-million milestone payment from Forest Laboratories Holdings Limited related to the development of MDX-8704. MDX-8704, a…
Personalized Medicine Drives Uptake of Next-Generation Sequencing in Europe, Finds Frost & Sullivan
The Western European next-generation sequencing (NGS) market is poised for steady growth, owing to the emergence of new applications, such as non-invasive prenatal testing and…
Eurofins Signs Agreement to Acquire ViraCor-IBT Laboratories
Eurofins Scientific, a global leader in bioanalytical testing and one of the world leaders in genomic services, has signed a definitive agreement to acquire ViraCor-IBT…
Ligand Signs $4.5-Million Agreement With Omthera Pharmaceuticals
Ligand Pharmaceuticals Incorporated recently announced it has entered into a licensing agreement and research collaboration with Omthera Pharmaceuticals, Inc., a wholly owned subsidiary of AstraZeneca…
